Crinetics Drug Patent Portfolio
Crinetics owns 1 orange book drug protected by 9 US patents Given below is the list of Crinetics's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12208092 | Compositions And Methods For Administering Paltusotine To Patients With Hepatic Impairment | 25 Mar, 2044 | Active |
| US11266641 | 07 Sep, 2041 | Active | |
| US11957674 | Formulations Of A Somatostatin Modulator | 07 Sep, 2041 | Active |
| US10464918 | Process Of Making Somatostatin Modulators | 16 Jan, 2039 | Active |
| US10351547 | Somatostatin Modulators And Uses Thereof | 12 Jul, 2037 | Active |
| US10597377 | Somatostatin Modulators And Uses Thereof | 12 Jul, 2037 | Active |
| US10875839 | Somatostatin Modulators And Uses Thereof | 12 Jul, 2037 | Active |
| US11414397 | Somatostatin Modulators And Uses Thereof | 12 Jul, 2037 | Active |
| US9896432 | Somatostatin Modulators And Uses Thereof | 12 Jul, 2037 | Active |
Latest Legal Activities on Crinetics's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Crinetics.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 18 Aug, 2025 | US11414397 |
| Email Notification | 22 Apr, 2025 | US9896432 |
| Email Notification | 22 Apr, 2025 | US10464918 |
| Mail Patent eCofC Notification | 22 Apr, 2025 | US11414397 |
| Mail Patent eCofC Notification | 22 Apr, 2025 | US10351547 |
| Recordation of Patent eCertificate of Correction | 22 Apr, 2025 | US10351547 |
| Patent eCofC Notification | 22 Apr, 2025 | US11414397 |
| Mail Patent eCofC Notification | 22 Apr, 2025 | US10464918 |
| Patent eCofC Notification | 22 Apr, 2025 | US10464918 |
| Recordation of Patent eCertificate of Correction | 22 Apr, 2025 | US10464918 |
| Recordation of Patent eCertificate of Correction | 22 Apr, 2025 | US11414397 |
| Email Notification | 22 Apr, 2025 | US11414397 |
| Patent eCofC Notification | 22 Apr, 2025 | US10351547 |
| Email Notification | 22 Apr, 2025 | US10351547 |
| Mail Patent eCofC Notification | 22 Apr, 2025 | US9896432 |
Crinetics's Family Patents
Crinetics Drug List
Given below is the complete list of Crinetics's drugs and the patents protecting them.
1. Palsonify
Palsonify is protected by 9 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12208092 | Compositions And Methods For Administering Paltusotine To Patients With Hepatic Impairment |
25 Mar, 2044
(18 years from now)
| Active |
| US11266641 |
07 Sep, 2041
(15 years from now)
| Active | |
| US11957674 | Formulations Of A Somatostatin Modulator |
07 Sep, 2041
(15 years from now)
| Active |
| US10464918 | Process Of Making Somatostatin Modulators |
16 Jan, 2039
(12 years from now)
| Active |
| US10351547 | Somatostatin Modulators And Uses Thereof |
12 Jul, 2037
(11 years from now)
| Active |
| US10597377 | Somatostatin Modulators And Uses Thereof |
12 Jul, 2037
(11 years from now)
| Active |
| US10875839 | Somatostatin Modulators And Uses Thereof |
12 Jul, 2037
(11 years from now)
| Active |
| US11414397 | Somatostatin Modulators And Uses Thereof |
12 Jul, 2037
(11 years from now)
| Active |
| US9896432 | Somatostatin Modulators And Uses Thereof |
12 Jul, 2037
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Palsonify's drug page